CCL3L1 Copy Number is a Strong Genetic Determinant of HIV Seropositivity in Caucasian Intravenous Drug Users
Overview
Authors
Affiliations
Background: A high copy number of CCL3L1, the most potent human immunodeficiency virus (HIV)-suppressive chemokine, associates with reduced HIV susceptibility. Whether CCL3L1 influences acquisition of multiple blood-borne infections (eg, hepatitis C virus [HCV], HIV, and hepatitis B virus [HBV] infections), which occur commonly among injection drug users (IDUs), is unknown.
Methods: We determined CCL3L1 copy number by real-time polymerase chain reaction among 374 Caucasian IDUs from Estonia; 285 were HCV positive, 208 were HIV positive, 177 were HCV and HIV positive, and 57 were HCV and HIV negative.
Results: In univariate and multivariate analyses, HCV and HBV seropositivity and duration of IDU each strongly predicted HIV seropositivity. A high CCL3L1 copy number (>2) was associated with an 80% reduced risk of acquiring HIV infection after adjusting for age, sex, HCV and HBV status, CCR5-Delta32 polymorphism, and IDU duration (odds ratio, 0.20; 95% confidence interval, 0.09-0.45). By contrast, CCL3L1 gene dose did not influence HCV seropositivity. Among HCV-positive IDUs, there was a 3.5-fold overrepresentation and 65% underrepresentation of a high CCL3L1 copy number among HCV-positive, HIV-negative subjects and HCV-positive, HIV-positive subjects, respectively.
Conclusion: Among IDUs with extensive exposure to HCV and HIV, CCL3L1 copy number is a major determinant of HIV seropositivity but not of HCV seropositivity. The contrasting distribution of a protective high CCL3L1 copy number among HCV-positive, HIV-negative IDUs versus HCV-positive, HIV-positive IDUs may reflect that HIV preferentially selects for subjects with a low CCL3L1 gene dose.
Chen Y, Li X, Liu S, Ao W, Lin J, Li Z Chin Med J (Engl). 2023; 136(22):2694-2705.
PMID: 37914674 PMC: 10684209. DOI: 10.1097/CM9.0000000000002918.
Vaill M, Kawanishi K, Varki N, Gagneux P, Varki A Physiol Rev. 2023; 103(3):2171-2229.
PMID: 36603157 PMC: 10151058. DOI: 10.1152/physrev.00040.2021.
Ribeiro G, Leon L, Perez R, Cuiza A, Vial P, Ferres M Viruses. 2019; 11(8).
PMID: 31349540 PMC: 6723883. DOI: 10.3390/v11080680.
Huik K, Avi R, Pauskar M, Kallas E, Jogeda E, Karki T PLoS One. 2016; 11(6):e0156850.
PMID: 27304910 PMC: 4909289. DOI: 10.1371/journal.pone.0156850.
Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
Jogeda E, Avi R, Pauskar M, Kallas E, Karki T, Des Jarlais D Infect Genet Evol. 2016; 43:83-5.
PMID: 27223634 PMC: 4949113. DOI: 10.1016/j.meegid.2016.05.022.